Literature DB >> 30156180

Barriers to Providing Prehospital Care to Ischemic Stroke Patients: Predictors and Impact on Care.

Timmy Li1, Jeremy T Cushman2, Manish N Shah3, Adam G Kelly4, David Q Rich5, Courtney M C Jones2.   

Abstract

IntroductionIschemic stroke treatment is time-sensitive, and barriers to providing prehospital care encountered by Emergency Medical Services (EMS) providers have been under-studied.Hypothesis/ProblemThis study described barriers to providing prehospital care, identified predictors of these barriers, and assessed the impact of these barriers on EMS on-scene time and administration of tissue plasminogen activator (tPA) in the emergency department (ED).
METHODS: A retrospective cohort study was performed using the Get With The Guidelines-Stroke (GWTG-S; American Heart Association [AHA]; Dallas, Texas USA) registry at two hospitals to identify ischemic stroke patients arriving by EMS. Variables were abstracted from prehospital and hospital medical records and merged with registry data. Barriers to care were grouped into themes. Logistic regression was used to identify predictors of barriers to care, and bi-variate tests were used to assess differences in EMS on-scene time and the proportion of patients receiving tPA between patients with and without barriers.
RESULTS: Barriers to providing prehospital care were documented for 15.5% of patients: 29.6% related to access, 26.7% communication, 23.0% extrication and transportation, 20.0% refusal, and 14.1% assessment/management. Non-white and non-black race (OR: 3.69; 95% CI, 1.63-8.36) and living alone (OR: 1.53; 95% CI, 1.05-2.23) were associated with greater odds of barriers to providing care. The EMS on-scene time was ≥15 minutes for 70.4% of patients who had a barrier to care, compared with 49.0% of patients who did not (P<.001). There was no significant difference in the proportion of patients who were administered tPA between those with and without barriers to care (14.1% vs 19.2%; P=.159).
CONCLUSIONS: Barriers to providing prehospital care were documented for a sizable proportion of ischemic stroke patients, with the majority related to patient access and communication, and occurred more frequently among non-white and non-black patients and those living alone. Although EMS on-scene time was longer for patients with barriers to care, the proportion of patients receiving tPA in the ED did not differ. LiT, CushmanJT, ShahMN, KellyAG, RichDQ, JonesCMC. Barriers to providing prehospital care to ischemic stroke patients: predictors and impact on care. Prehosp Disaster Med. 2018;33(5):501-507.

Entities:  

Keywords:  AHA American Heart Association; ED emergency department; EMS Emergency Medical Services; GWTG-S Get With The Guidelines-Stroke; tPA tissue plasminogen activator; Emergency Medical Services; prehospital; stroke

Mesh:

Year:  2018        PMID: 30156180     DOI: 10.1017/S1049023X18000766

Source DB:  PubMed          Journal:  Prehosp Disaster Med        ISSN: 1049-023X            Impact factor:   2.040


  4 in total

1.  Do methods of hospital pre-alerts influence the on-scene times for acute pre-hospital stroke patients? A retrospective observational study.

Authors:  Jacob Gunn
Journal:  Br Paramed J       Date:  2021-09-01

Review 2.  Prehospital stroke care, a narrative review.

Authors:  Zi Wang; Yuchuan Ding; Paul Fu
Journal:  Brain Circ       Date:  2018-12-31

3.  Call to hospital times for suspected stroke patients in the North East of England: a service evaluation.

Authors:  Daniel Haworth; Graham McClelland
Journal:  Br Paramed J       Date:  2019-09-01

4.  Short and long-term impact of four sets of actions on acute ischemic stroke management in Rhône County, a population based before-and-after prospective study.

Authors:  A M Schott; A Termoz; M Viprey; K Tazarourte; C Della Vecchia; E Bravant; N Perreton; N Nighoghossian; S Cakmak; S Meyran; B Ducreux; C Pidoux; T Bony; M Douplat; V Potinet; A Sigal; Y Xue; L Derex; J Haesebaert
Journal:  BMC Health Serv Res       Date:  2021-01-04       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.